The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
University of Oxford · University College London · +34 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,459
total citations
- FWCI
- 245.97
- Percentile
- 100%
- References
- 28
Citations per year
Authors
50Topics & keywords
Topics
Keywords
- Simvastatin
- Ezetimibe
- Medicine
- Kidney disease
- Placebo
- Internal medicine
- Cholesterol
- Statin
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.